631 related articles for article (PubMed ID: 30667502)
1. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.
Schwimmer JB; Ugalde-Nicalo P; Welsh JA; Angeles JE; Cordero M; Harlow KE; Alazraki A; Durelle J; Knight-Scott J; Newton KP; Cleeton R; Knott C; Konomi J; Middleton MS; Travers C; Sirlin CB; Hernandez A; Sekkarie A; McCracken C; Vos MB
JAMA; 2019 Jan; 321(3):256-265. PubMed ID: 30667502
[TBL] [Abstract][Full Text] [Related]
2. Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease.
Cohen CC; Li KW; Alazraki AL; Beysen C; Carrier CA; Cleeton RL; Dandan M; Figueroa J; Knight-Scott J; Knott CJ; Newton KP; Nyangau EM; Sirlin CB; Ugalde-Nicalo PA; Welsh JA; Hellerstein MK; Schwimmer JB; Vos MB
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34907907
[TBL] [Abstract][Full Text] [Related]
3. Study protocol for a randomized, controlled trial using a novel, family-centered diet treatment to prevent nonalcoholic fatty liver disease in Hispanic children.
Welsh JA; Pyo E; Huneault H; Gonzalez Ramirez L; Alazraki A; Alli R; Dunbar SB; Khanna G; Knight-Scott J; Pimentel A; Reed B; Rodney-Somersall C; Santoro N; Umpierrez G; Vos MB
Contemp Clin Trials; 2023 Jun; 129():107170. PubMed ID: 37019180
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology.
Dowla S; Pendergrass M; Bolding M; Gower B; Fontaine K; Ashraf A; Soleymani T; Morrison S; Goss A
Contemp Clin Trials; 2018 May; 68():95-101. PubMed ID: 29601997
[TBL] [Abstract][Full Text] [Related]
5. Clinical Intervention to Reduce Dietary Sugar Does Not Affect Liver Fat in Latino Youth, Regardless of PNPLA3 Genotype: A Randomized Controlled Trial.
Schmidt KA; Jones RB; Rios C; Corona Y; Berger PK; Plows JF; Alderete TL; Fogel J; Hampson H; Hartiala JA; Cai Z; Allayee H; Nayak KS; Sinatra FR; Harlan G; Pickering TA; Salvy SJ; Mack WJ; Kohli R; Goran MI
J Nutr; 2022 Jul; 152(7):1655-1665. PubMed ID: 35218194
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
[TBL] [Abstract][Full Text] [Related]
7. Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial.
Gardner CD; Trepanowski JF; Del Gobbo LC; Hauser ME; Rigdon J; Ioannidis JPA; Desai M; King AC
JAMA; 2018 Feb; 319(7):667-679. PubMed ID: 29466592
[TBL] [Abstract][Full Text] [Related]
8. Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial.
Hansen CD; Gram-Kampmann EM; Hansen JK; Hugger MB; Madsen BS; Jensen JM; Olesen S; Torp N; Rasmussen DN; Kjærgaard M; Johansen S; Lindvig KP; Andersen P; Thorhauge KH; Brønd JC; Hermann P; Beck-Nielsen H; Detlefsen S; Hansen T; Højlund K; Thiele MS; Israelsen M; Krag A
Ann Intern Med; 2023 Jan; 176(1):10-21. PubMed ID: 36508737
[TBL] [Abstract][Full Text] [Related]
9. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
Lavine JE; Schwimmer JB; Van Natta ML; Molleston JP; Murray KF; Rosenthal P; Abrams SH; Scheimann AO; Sanyal AJ; Chalasani N; Tonascia J; Ünalp A; Clark JM; Brunt EM; Kleiner DE; Hoofnagle JH; Robuck PR;
JAMA; 2011 Apr; 305(16):1659-68. PubMed ID: 21521847
[TBL] [Abstract][Full Text] [Related]
10. Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.
Lim SL; Johal J; Ong KW; Han CY; Chan YH; Lee YM; Loo WM
JMIR Mhealth Uhealth; 2020 Apr; 8(4):e14802. PubMed ID: 32281943
[TBL] [Abstract][Full Text] [Related]
11. Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial.
Dorosti M; Jafary Heidarloo A; Bakhshimoghaddam F; Alizadeh M
Br J Nutr; 2020 Feb; 123(3):328-336. PubMed ID: 31685037
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis.
Lawitz EJ; Coste A; Poordad F; Alkhouri N; Loo N; McColgan BJ; Tarrant JM; Nguyen T; Han L; Chung C; Ray AS; McHutchison JG; Subramanian GM; Myers RP; Middleton MS; Sirlin C; Loomba R; Nyangau E; Fitch M; Li K; Hellerstein M
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1983-1991.e3. PubMed ID: 29705265
[TBL] [Abstract][Full Text] [Related]
13. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
Razavi Zade M; Telkabadi MH; Bahmani F; Salehi B; Farshbaf S; Asemi Z
Liver Int; 2016 Apr; 36(4):563-71. PubMed ID: 26503843
[TBL] [Abstract][Full Text] [Related]
14. Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet.
Kabisch S; Bäther S; Dambeck U; Kemper M; Gerbracht C; Honsek C; Sachno A; Pfeiffer AFH
Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385034
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China.
Liu Z; Jin P; Liu Y; Zhang Z; Wu X; Weng M; Cao S; Wang Y; Zeng C; Yang R; Liu C; Sun P; Tian C; Li N; Zeng Q
Nutr J; 2024 Jun; 23(1):64. PubMed ID: 38872173
[TBL] [Abstract][Full Text] [Related]
16. Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
Zhang HJ; He J; Pan LL; Ma ZM; Han CK; Chen CS; Chen Z; Han HW; Chen S; Sun Q; Zhang JF; Li ZB; Yang SY; Li XJ; Li XY
JAMA Intern Med; 2016 Aug; 176(8):1074-82. PubMed ID: 27379904
[TBL] [Abstract][Full Text] [Related]
17. Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial.
Simon TG; Wilechansky RM; Stoyanova S; Grossman A; Dichtel LE; Lauer GM; Miller KK; Hoshida Y; Corey KE; Loomba R; Chung RT; Chan AT
JAMA; 2024 Mar; 331(11):920-929. PubMed ID: 38502074
[TBL] [Abstract][Full Text] [Related]
18. Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Sangouni AA; Nadjarzadeh A; Rohani FS; Sharuni F; Zare Z; Rahimpour S; Hojjat H; Hosseinzadeh M
Eur J Nutr; 2024 Feb; 63(1):95-105. PubMed ID: 37855891
[TBL] [Abstract][Full Text] [Related]
19. Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trial.
Khodami B; Hatami B; Yari Z; Alavian SM; Sadeghi A; Varkaneh HK; Santos HO; Hekmatdoost A
Eur J Clin Nutr; 2022 Jul; 76(7):987-994. PubMed ID: 35058605
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
